Daily Mail News UK – Health
An experimental cancer treatment has a 90 percent success rate in patients with multiple myeloma, one of the most common blood cancers in the world.
Researchers at Hadassah-University Medical Center in Jerusalem, Israel, used a treatment called Chimeric Antigen Receptor T-Cell Therapy, or CAR-T, which boosts the patient’s own immune system to destroy cancer cells.
Of the 74 patients with multiple myeloma who were given the drug, 90 percent went into complete remission, meaning they had no signs of cancer remaining.